Latest Breaking News On - Cannabics pharmaceuticals - Page 8 : vimarsana.com

The European Patent Office Grants Cannabics Pharmaceuticals Patent for Company s Personalized Medicine Drug Discovery Technology USA - English Share this article Share this article TEL AVIV, Israel and BETHESDA, Md., May 25, 2021 /PRNewswire/ Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, announced today that the company s patent titled: System and Method for High Throughput Screening of Cancer Cells  has been granted by the European Patent Office. Outside the European territory, corresponding patents under the same title have already been granted in Israel and in South Africa. Further to that, corresponding patents with said title are also currently under examination in numerous other territories including the US and Canada, as well as in Mexico where earlier this month the company received Notice of Allowance from the Mexican Patent and Trademark Office (IMPI).

South africaEyal ballanGabriel yarivFacebook cannabicspharmaceuticalsInstagram cannabicsEuropean patent officeCompany on twitter cannabicsMinistry of healthExchange commissionTrademark officeCannabics pharmaceuticalsPrnewswire cannabics pharmaceuticals incCannabics pharmaceuticals incHigh throughput screeningEuropean patentMexican patent